期刊文献+

TNF抑制剂依那西普治疗强直性脊柱炎60例分析 被引量:2

原文传递
导出
摘要 目的分析TNF抑制剂依那西普治疗强直性脊柱炎临床效果。方法 60例强直性脊柱炎,依那西普成人剂量为25mg,皮下注射,每周2次,其中50mg每周1次20例,每次在不同部位注射与前次注射部位至少相距3cm。结果平均随访10个月,60例患者总有效率90%(54/60),除2例严重皮肤瘙痒,其余不良反应均较轻。结论依那西普治疗强直性脊柱炎患者有效率高,如果患者早期使用TNF抑制剂依那西普,可以在症状控制后停用该药,必要时可重复使用。
出处 《中国误诊学杂志》 CAS 2012年第3期650-651,共2页 Chinese Journal of Misdiagnostics
  • 相关文献

参考文献4

二级参考文献12

  • 1赵福涛,管剑龙,韩星海.甲氨蝶呤治疗强直性脊柱炎髋关节病变的临床研究[J].中华风湿病学杂志,2007,11(4):213-216. 被引量:11
  • 2Davis JC,Van der Heijde D,Dongados M,et al.Reduction in health related quality of life in patients with ankylosing spondylitis and improvements with etanereept therapy[J].Arthritis Rheum,2005,53:494-501.
  • 3Gomez-Reino JJ,Carmona L,Valverde VR,et al.Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk:a multicenter active-surveillance report[J].Arthritis Rheum,2003,48:2122-2127.
  • 4Antoni C,Braun J.Side effects of anti-TNF therapy:current knowledge[J].Clin Exp Rheumatol,2002,20(28):152-157.
  • 5Fleischmann R,Banmgartner SW,Weisman MH.Long term safety of etanereept in elderly subjects with rheumatic diseases[J].Ann Rheum Dis,2006,65(3):379-384.
  • 6Ruddy S Harris Jr ED, Sledge CB. Kelley's textbook of rheumatology [M]. 6th ed. Philadelphia: W. B. Saunders Company, 2001: 1039 - 1054.
  • 7van der Linden S, Valkenhurg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylilis. A proposal for modification of the New York eriteria[J . Arthritis Rheum. 1984, 27(4): 361 -368.
  • 8Garrett S, Jenkinson T, Kennedy LG, et al. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index[J]. J Rheumatol, 1994, 21 (12): 2286 -2291.
  • 9Calin A, Garrett S, Whitelock fl, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index [J]. J Rheumatol, 1994, 21(12): 2281 -2285.
  • 10Dalyan M, Guner A, Tuncer S, et al. Disability in ankylosing spondylitis[J].Disabil Rehabil, 1999, 21 (2): 74 -79.

共引文献19

同被引文献20

  • 1刘扬渝,董碧蓉.类风湿性关节炎药物治疗及策略进展[J].现代临床医学,2006,32(1):74-76. 被引量:3
  • 2Saadoan D,Deslandre CJ,Allanore Y,et al. Sustained response toinfliximab in 2 patients with refractory relapsing polyehondritis[J]. J Rheumatol,2003,30(6) :1394 - 1395.
  • 3Carter JD. Treatment of polychondritis with a TNF antagonist[J].J Rheumatol,2005,32(7) :1413.
  • 4Subrahmanyam P, BMakrishnan C, Daagupta B. Sustainedresponse to etanereept after failing infliximab in a patient withrelapsing polychondritis with tracheomalacia[ J]. Scand J Rheu-matol, 2008 ,37(3 ) :239 .240.
  • 5梁东风,黄烽.抗TNF-a疗法治疗银屑病关节炎和银屑病[J].中国药物应用与检测,2005,3:39.42.
  • 6Cremer MA, Rosloniec EF, Kang AH. The cartilage collagens : areview of their structure,organization,and role in the pathogenesisof experimental arthritis in animals and in human rheumaticdisease[J]. J Mol Med,1998,76(4) :275 -288.
  • 7Lahmer T,Treiber M,von Werder A,et al. Relapsing polychon-dritis :An autoimmune disease with many faces [ J]. AutoimmunRev,2010,9(8) :540-546.
  • 8莫颖倩,戴冽.复发性多软骨炎的诊断和治疗现状[J].新医学,2007,38(11):767-769. 被引量:10
  • 9Chen Lvyi, Mola Mahmutjian, Deng Xukun, et al . Dolichos falcata Klein attenuated the inflammation induced by monoso- dium urate crystals in vivo and in vitro.[J].J Ethnopharma- col ,2013,150(2) :545-552.
  • 10Rudwaleit M,Claudepierre P,Wordsworth P, et al .Effective- ness,safety,and predictors of good clinical response in 1 250 patients treated with adalimumab for active ankylosing spon- dylitis[J].J Rheumatol, 2009,36 (4): 801-808.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部